{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:22:31Z","timestamp":1787318551554,"version":"build-2736575974"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Moxifloxacin (MFLX) frequently induces dysglycemia when used in the treatment of infectious diseases, particularly in patients with diabetes. However, the mechanism through which MFLX affects host glucose metabolism remains unclear. This study aimed to investigate the possible mechanism underlying MFLX-induced hyperglycemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we investigated the short-term (3\u00a0days) and long-term (14\u00a0days) effects of MFLX on glucose metabolism in normal and type 2 diabetic GK rats. After oral administration of 40\u00a0mg\/kg of MFLX, blood glucose, insulin, GLP-1, and fibroblast growth factor 15 (FGF15) levels in the blood of rats, as well as bile acids in both blood and feces, and gut microbiota, were examined. Liver and ileum tissues were promptly harvested for detecting the expression of hepatic 7\u03b1-hydroxylase (CYP7A1) and intestinal Takeda G-protein-coupled receptor 5 (TGR5) and farnesoid X receptor (FXR). In addition, we explored the effect of secondary bile acids (SBAs) on GLP-1 secretion in NCI-H716 cells, and observed the direct effect of MFLX on the expression of CYP7A1 in HepG2 cells and TGR5, FXR in NCI-H716 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      It was demonstrated that MFLX induced hyperglycemia in diabetic rats, with a more pronounced reduction in serum insulin, GLP-1, and FGF15 levels than observed in normal rats. Gut microbiota associated with SBAs metabolism were significantly reduced, leading to decreased intestinal deoxycholic acid (DCA) and lithocholic acid (LCA).\n                      <jats:italic>In vitro<\/jats:italic>\n                      studies revealed that DCA and LCA (25\u00a0\u03bcM, 50\u00a0\u03bcM, and 100\u00a0\u03bcM) promoted GLP-1 secretion in a concentration-dependent manner in NCI-H716 cells. Meanwhile, we observed that the expression of intestinal TGR5 and FXR significantly downregulated, whereas CYP7A1 expression in liver was increased in GK rats after MFLX treatment. MFLX itself (0.1\u00a0\u03bcM, 1\u00a0\u03bcM, and 10\u00a0\u03bcM) did not directly altered TGR5 or FXR expressions in NCI-H716 cells, nor did it alter CYP7A1 expression in HepG2 cells, which indicated that the impact of MFLX on glucose metabolism was primarily induced by changes in bile acids metabolism resulting from alterations in the gut microbiota.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our studies showed MFLX more likely to cause hyperglycemia when used in diabetic states and highlighted the critical role of gut microbiota-SBAs-TGR5\/FXR pathway in MFLX-induced hyperglycemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1569856","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:49:19Z","timestamp":1743770959000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Suppressed intestinal secondary bile acids in moxifloxacin-induced hyperglycemia: studies in normal and diabetic GK rats"],"prefix":"10.3389","volume":"16","author":[{"given":"Yewen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/15733998113099990069","article-title":"Goto-Kakizaki rats: its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus","volume":"9","author":"Akash","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/Tcrm.S284171","article-title":"How safe are fluoroquinolones for diabetic patients? A systematic review of dysglycemic and neuropathic effects of fluoroquinolones","volume":"17","author":"Althaqafi","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s00345-022-04055-7","article-title":"Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study","volume":"40","author":"Bartoletti","year":"2022","journal-title":"World J. Urology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"114572","DOI":"10.1016\/j.celrep.2024.114572","article-title":"Spatial analysis of murine microbiota and bile acid metabolism during amoxicillin treatment","volume":"43","author":"Beekman","year":"2024","journal-title":"Cell. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.taap.2018.11.012","article-title":"Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats","volume":"363","author":"Behr","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciw209","article-title":"Association between initial route of fluoroquinolone administration and outcomes in patients hospitalized for community-acquired pneumonia","volume":"63","author":"Belforti","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"63665","DOI":"10.18632\/oncotarget.18885","article-title":"Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bbadis.2017.09.019","article-title":"Nuclear receptor FXR, bile acids and liver damage: introducing the progressive familial intrahepatic cholestasis with FXR mutations","volume":"1864","author":"Cariello","year":"2018","journal-title":"Biochimica Biophysica Acta-Molecular Basis Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1483-+","DOI":"10.1016\/j.cmet.2021.04.009","article-title":"Hypothalamic bile acid-TGR5 signaling protects from obesity","volume":"33","author":"Castellanos-Jankiewicz","year":"2021","journal-title":"Cell. Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2192155","DOI":"10.1080\/19490976.2023.2192155","article-title":"Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes","volume":"15","author":"Chen","year":"2023","journal-title":"Gut Microbes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/cid\/cit439","article-title":"Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in taiwan","volume":"57","author":"Chou","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E279","DOI":"10.1152\/ajpendo.00156.2024","article-title":"The role of FGF19 in metabolic regulation: insights from preclinical models to clinical trials","volume":"327","author":"De Carvalho","year":"2024","journal-title":"Am. J. Physiology-Endocrinology Metabolism"},{"key":"B15","doi-asserted-by":"publisher","first-page":"134821","DOI":"10.1016\/j.jhazmat.2024.134821","article-title":"Butylparaben induces glycolipid metabolic disorders in mice via disruption of gut microbiota and FXR signaling","volume":"474","author":"Du","year":"2024","journal-title":"J. Hazard Mater"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.clinthera.2021.03.006","article-title":"Clinical benefits and cost-effectiveness of moxifloxacin as initial treatment for community-acquired pneumonia: a meta-analysis and economic evaluation","volume":"43","author":"Du","year":"2021","journal-title":"Clin. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"iv9","DOI":"10.1093\/jac\/dkab351","article-title":"Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics","volume":"76","author":"Eckmann","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pcd.2014.10.006","article-title":"Dysglycemia associated with quinolones","volume":"9","author":"El Ghandour","year":"2015","journal-title":"Prim. Care Diabetes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/17460441.2021.1916465","article-title":"The identification of farcesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease","volume":"16","author":"Fiorucci","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1027212","DOI":"10.3389\/fphar.2022.1027212","article-title":"Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000450908","article-title":"Intestinal farnesoid X receptor signaling modulates metabolic disease","volume":"35","author":"Gonzalez","year":"2017","journal-title":"Dig. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4067\/s0034-98872018000500618","article-title":"Dysglycemia asociada a fluoroquinolones: una revisi\u00f3n estructurada","volume":"146","author":"Granados","year":"2018","journal-title":"Rev. Med. Chil."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.3390\/nu15234864","article-title":"Probiotic Pediococcus pentosaceus Li05 improves cholestasis through the FXR-SHP and FXR-FGF15 pathways Li05 improves cholestasis through the FXR-SHP and FXR-FGF15 pathways","volume":"15","author":"Han","year":"2023","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/srep00430","article-title":"TGR5 potentiates GLP-1 secretion in response to anionic exchange resins","volume":"2","author":"Harach","year":"2012","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8558","DOI":"10.1096\/fj.201902618RR","article-title":"Capsaicin improves glucose homeostasis by enhancing glucagon-like peptide-1 secretion through the regulation of bile acid metabolism via the remodeling of the gut microbiota in male mice","volume":"34","author":"Hui","year":"2020","journal-title":"Faseb J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.tiv.2020.104786","article-title":"Fluoroquinolones suppress gluconeogenesis by inhibiting fructose 1,6-bisphosphatase in primary monkey hepatocytes","volume":"65","author":"Iguchi","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"B29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1248\/bpb.b12-00930","article-title":"Effects of moxifloxacin on serum glucose concentrations in rats","volume":"36","author":"Ishiwata","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"B30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterology and Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","article-title":"Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease","volume":"43","author":"Jiao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-pharmtox-032322-093904","article-title":"Fibroblast growth factor-based pharmacotherapies for the treatment of obesity-related metabolic complications","volume":"63","author":"Jin","year":"2023","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/dom.14851","article-title":"A randomized, double-blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women","volume":"25","author":"Juhl","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2147\/TCRM.S81280","article-title":"Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia","volume":"11","author":"Kabbara","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling Axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s12272-014-0362-0","article-title":"Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation","volume":"37","author":"Kim","year":"2014","journal-title":"Archives Pharmacal Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.3390\/microorganisms11112730","article-title":"The role of gut microbiota-derived lithocholic acid, deoxycholic acid and their derivatives on the function and differentiation of immune cells","volume":"11","author":"Kiriyama","year":"2023","journal-title":"Microorganisms"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s41467-022-29589-7","article-title":"Gut microbiota-bile acid crosstalk contributes to the rebound weight gain after calorie restriction in mice","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"110953","DOI":"10.1016\/j.biopha.2020.110953","article-title":"Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db\/db mice","volume":"132","author":"Li","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"154982","DOI":"10.1016\/j.phymed.2023.154982","article-title":"Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway","volume":"119","author":"Li","year":"2023","journal-title":"Phytomedicine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23295","DOI":"10.1021\/acs.jafc.4c06392","article-title":"Arabinoxylan alleviates obesity by regulating gut microbiota and bile acid metabolism","volume":"72","author":"Lin","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6645970","DOI":"10.1155\/2021\/6645970","article-title":"Gut dysbiosis and abnormal bile acid metabolism in colitis-associated cancer","volume":"2021","author":"Liu","year":"2021","journal-title":"Gastroenterol. Res. Pract."},{"key":"B43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.apsb.2023.11.011","article-title":"Mechanism of action of the bile acid receptor TGR5 in obesity","volume":"14","author":"Lun","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117627","DOI":"10.1016\/j.jep.2023.117627","article-title":"PuRenDan alleviates type 2 diabetes mellitus symptoms by modulating the gut microbiota and its metabolites","volume":"322","author":"Ma","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2393766","DOI":"10.1080\/19490976.2024.2393766","article-title":"Bile acids impact the microbiota, host, and C. difficile dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics","volume":"16","author":"McMillan","year":"2024","journal-title":"Gut Microbes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40168-022-01264-5","article-title":"Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity","volume":"10","author":"M\u00fcnzker","year":"2022","journal-title":"Microbiome"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farcesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-021-00398-4","article-title":"Central anorexigenic actions of bile acids are mediated by TGR5","volume":"3","author":"Perino","year":"2021","journal-title":"Nat. Metab."},{"key":"B49","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.3390\/molecules26237066","article-title":"Taurochenodeoxycholic acid increases cAMP content via specially interacting with bile acid receptor TGR5","volume":"26","author":"Qi","year":"2021","journal-title":"Molecules"},{"key":"B50","doi-asserted-by":"publisher","first-page":"6741745","DOI":"10.1155\/2016\/6741745","article-title":"HERG protein plays a role in moxifloxacin-induced hypoglycemia","volume":"2016","author":"Qiu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e14072","DOI":"10.1111\/ijcp.14072","article-title":"Effect of ciprofloxacin vs levofloxacin on QTc-interval and dysglycemia in diabetic and non-diabetic patients","volume":"75","author":"Saad","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17298","DOI":"10.3390\/ijms242417298","article-title":"The role of the FGF19 family in the pathogenesis of gestational diabetes: a narrative review","volume":"24","author":"Sadowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/MCO.0b013e3283547171","article-title":"Role of fibroblast growth factor 19 in the control of glucose homeostasis","volume":"15","author":"Schaap","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1124\/dmd.115.065276","article-title":"Importance of large intestine in regulating bile acids and glucagon-like peptide-1 in germ-free mice","volume":"43","author":"Selwyn","year":"2015","journal-title":"Drug Metabolism Dispos."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s40200-023-01234-0","article-title":"Hypoglycemia and anxiolysis mediated by levofloxacin treatment in diabetic rats","volume":"22","author":"Singh","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1127743","DOI":"10.3389\/fimmu.2023.1127743","article-title":"Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity","volume":"14","author":"Su","year":"2023","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cid\/ciab934","article-title":"Fosfomycin vs ciprofloxacin as oral step-down treatment for Escherichia coli febrile urinary tract infections in women: a randomized, placebo-controlled, double-blind, multicenter trial","volume":"75","author":"Ten Doesschate","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jgr.2022.03.006","article-title":"Compound K attenuates hyperglycemia by enhancing glucagon-like peptide-1 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism","volume":"46","author":"Tian","year":"2022","journal-title":"J. Ginseng Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/cphy.c190007","article-title":"Intestinal absorption of bile acids in Health and disease","volume":"10","author":"Ticho","year":"2019","journal-title":"Compr. Physiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat. Commun."},{"key":"B62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell. Metab."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e33896","DOI":"10.1097\/MD.0000000000033896","article-title":"Comprehensive clinical evaluation of moxifloxacin: a retrospective study","volume":"102","author":"Wang","year":"","journal-title":"Med. Baltim."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2274124","DOI":"10.1080\/19490976.2023.2274124","article-title":"Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling","volume":"15","author":"Wang","year":"","journal-title":"Gut Microbes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/1751-7915.14293","article-title":"Akkermansia muciniphila alleviates high-fat-diet-related metabolic-associated fatty liver disease by modulating gut microbiota and bile acids","volume":"16","author":"Wu","year":"2023","journal-title":"Microb. Biotechnol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e00518","DOI":"10.1128\/spectrum.05072-22","article-title":"FXR signaling-mediated bile acid metabolism is critical for alleviation of cholesterol gallstones by lactobacillus strains","volume":"11","author":"Ye","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0203223","DOI":"10.1128\/mbio.02032-23","article-title":"Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases","volume":"15","author":"Zeng","year":"2024","journal-title":"Mbio"},{"key":"B68","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ebiom.2018.05.026","article-title":"Takeda G protein-coupled receptor 5-mechanistic target of rapamycin complex 1 signaling contributes to the increment of glucagon-like peptide-1 production after roux-en-Y gastric bypass","volume":"32","author":"Zhai","year":"2018","journal-title":"EBioMedicine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1039\/d3fo04378a","article-title":"Dietary nobiletin regulated cefuroxime- and levofloxacin-associated gut microbiota-metabolism imbalance and intestinal barrier dysfunction in mice","volume":"15","author":"Zhan","year":"2024","journal-title":"Food and Funct."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1189971","DOI":"10.3389\/fphar.2023.1189971","article-title":"Ameliorative effect of Aconite aqueous extract on diarrhea is associated with modulation of the gut microbiota and bile acid metabolism","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell. Metab."},{"key":"B72","doi-asserted-by":"publisher","first-page":"9738","DOI":"10.1021\/acs.jafc.3c00810","article-title":"Diets enriched in sugar, refined, or whole grain differentially influence plasma cholesterol concentrations and cholesterol metabolism pathways with concurrent changes in bile acid profile and gut microbiota composition in ApoE(-\/-) mice","volume":"71","author":"Zhou","year":"2023","journal-title":"J. Agric. Food Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1569856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:49:20Z","timestamp":1743770960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1569856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":72,"alternative-id":["10.3389\/fphar.2025.1569856"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1569856","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1569856"}}